je.st
news
Home
› Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes
Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes
2013-07-31 08:51:41| drugdiscoveryonline News Articles
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva Cardiomyocytes for drug discovery and early development cardio toxicity screening services
Tags: services
drug
discovery
drug discovery
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||